GlassScriptPhysician profile
Noah Jiji Simon
NPI 1831887207
$762.77
in general payments reported to CMS, 2019-2025
12 companies · $650 in 2025
The $650 reported for 2025 was more than what 91% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.75 · 2024: $89.65 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.82 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $202.70 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $173.94 | 2024-2025 | Myfembree |
| Shield Therapeutics INC | $82.77 | 2025 | |
| Lilly USA, LLC | $60.66 | 2025 | Zepbound |
| Novo Nordisk INC | $59.29 | 2025 | Wegovy, Ozempic, Rybelsus |
| Viiv Healthcare Company | $51.91 | 2025 | Apretude |
| Mayne Pharma Commercial LLC | $29.61 | 2024 | |
| Exeltis, USA INC. | $23.37 | 2025 | Slynd |
| Medtronic, INC. | $22.75 | 2023 | Interstim |
| Channel Medsystems, INC. | $21.55 | 2024 | |
| Currax Pharmaceuticals LLC | $17.14 | 2025 | Contrave |
| Evofem Biosciences, INC. | $17.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.